The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
Abstract
The treatment of inflammatory bowel disease (IBD) has been revolutionised over the past decade by the increasing use of immunomodulators, mainly azathioprine (AZA)/6-mercaptopurine (6-MP) and methotrexate (MTX), together with the advent of biological therapy. Immunomodulators are being used more often and earlier in the course of the disease. 1 The introduction of biologic agents, especially inhibitors of the key proinflammatory cytokine, tumor necrosis factor alpha (TNF-α) initiated a new therapeutic era, whose use has grown continuously since their introduction in 1998. 2 With such immunomodulation, the potential for opportunistic infection is a key safety concern for patients with IBD. Opportunistic infections pose particular problems for the clinician: they are often difficult to recognise and are associated with appreciable morbidity or mortality, because they are potentially serious and hard to treat effectively. Enhancing awareness and improving the knowledge of gastroenterologists about opportunistic infections are important elements to optimise patient outcomes through the development of preventive or early diagnostic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–251 of 251
A randomised placebo controlled trial of pegylated interferon α in active ulcerative colitis
Tilg, H., Vogelsang, H., Ludwiczek, O., Lochs, H., Kaser, A., Colombel, J.-F., Ulmer, H., Rutgeerts, P., Krüger, S., Cortot, A., et al. (2003) · Gut · doi:10.1136/gut.52.12.1728 · Cited by 81
Self-citationDisseminated Primary Varicella after Initiation of Infliximab for Crohn's Disease
Leung, V. S., Nguyen, M. T., & Bush, T. M. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.41389_7.x · Cited by 80
Role of Infections in the Manifestation or Reactivation of Inflammatory Bowel Diseases
Stallmach, A., & Carstens, O. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200205000-00009 · Cited by 80
Is Crohn’s disease due to defective immunity?
Korzenik, J. R. (2006) · Gut · doi:10.1136/gut.2006.095588 · Cited by 72
Epstein-Barr Virus Viral Load in Crohn’s Disease
Reijasse, D., Lependeven, C., Cosnes, J., Dehée, A., Gendre, J., Nicolas, J., & Beaugerie, L. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200403000-00004 · Cited by 72
The Self-Limited Nature of Chronic Idiopathic Diarrhea
Afzalpurkar, R. G., Schiller, L. R., Little, K. H., Santangelo, W. C., & Fordtran, J. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212243272605 · Cited by 71
Vanhoof, J., Landewe, S., Wijngaerden, E. V., & Geusens, P. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2002.004598 · Cited by 68
Toward an improved laboratory definition of Listeria monocytogenes virulence
Liu, D., Lawrence, M. L., Ainsworth, A. J., & Austin, F. W. (2007) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2007.07.045 · Cited by 68
Clinical manifestations, treatment and control of infections caused by Clostridium difficile
Bouza, E., Muñóz, P., & Alonso, R. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01165.x · Cited by 68
Listeria Meningitis Associated with Infliximab
Bowie, V. L., Snella, K. A., Gopalachar, A. S., & Bharadwaj, P. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d151 · Cited by 67
Influenza vaccine antibody responses in lung transplant recipients
Hayney, M. S., Welter, D. L., Francois, M. L., et al. (2004) · Progress in Transplantation · doi:10.7182/prtr.14.4.g5417348370w2n83 · Cited by 67
The influence of prednisolone on the recirculation of peripheral blood lymphocytes in vivo
Bloemena, E., Weinreich, S. S., & Schellekens, P. T. A. (1990) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb03310.x · Cited by 66
DEROUX, A., MARX, A., Burkhardt, O., Schweiger, B., Borkowski, A., Banzhoff, A., Pletz, M. W., & Lode, H. M. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.10.007 · Cited by 65
Methods to Avoid Infections in Patients with Inflammatory Bowel Disease
Aberra, F. N., & Lichtenstein, G. R. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000160742.91602.b7 · Cited by 64
Risk for Active Tuberculosis in Inflammatory Bowel Disease Patients
Aberra, F. N., Stettler, N., Brensinger, C. M., Lichtenstein, G. R., & Lewis, J. D. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.04.007 · Cited by 61
Severe Pneumococcal Pneumonia Following Treatment with Infliximab for Crohn's Disease
Ritz, M. A., & Jost, R. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200111000-00009 · Cited by 61
Listeria infections associated with infliximab: case reports
Kesteman, T., Yombi, J. C., Gigi, J., & Durez, P. (2007) · Clinical Rheumatology · doi:10.1007/s10067-007-0660-8 · Cited by 57
Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone
Singh, S. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040563 · Cited by 57
Beltrán, B., Nos, P., Bastida, G., Iborra, M., Hoyos, M., & Ponce, J. (2006) · Gut · doi:10.1136/gut.2006.101386 · Cited by 55
Quan, V., Saunders, B. P., Hicks, B. H., & Sladen, G. E. (1997) · BMJ · doi:10.1136/bmj.314.7077.363 · Cited by 51
Cryptococcal meningitis in a patient treated with infliximab.
Muñoz, P., Giannella, M., Valerio, M., Soria, T., Díaz, F., Longo, J. L., & Bouza, E. (2007) · Diagnostic microbiology and infectious disease · doi:10.1016/j.diagmicrobio.2006.10.014 · Cited by 50
Wallis, R. S., Kalayjian, R. C., Jacobson, J. M., Fox, L. M., Purdue, L., Shikuma, C. M., Arakaki, R. F., Snyder, S. W., Coombs, R. W., Bosch, R. J., et al. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200303010-00006 · Cited by 48
The Use of Antiviral Drugs for Influenza: Recommended Guidelines for Practitioners
Allen, U., Aoki, F. Y., & Stiver, H. G. (2006) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2006/165940 · Cited by 48
DiRienzo, A. G., van der Horst, C., Finkelstein, D. M., Frame, P. T., Bozzette, S. A., & Tashima, K. T. (2002) · AIDS Research and Human Retroviruses · doi:10.1089/08892220252779629 · Cited by 47
Kaur, N. J., & Mahl, T. C. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000042246.58984.98 · Cited by 46
Zabana, Y., Domènech, E., López–Sanromán, A., Beltrán, B., Cabriada, J. L., Saro, C. M., Araméndiz, R., Ginard, D., Hinojosa, J., Gisbert, J. P., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20496 · Cited by 46
Self-citationElkayam, O., Ablin, J. N., & Caspi, D. (2006) · Autoimmunity Reviews · doi:10.1016/j.autrev.2006.09.005 · Cited by 45
Obrador, A., Román, A. L. S., Muñóz, P., Fortün, J., & Gassull, M. À. (2003) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(03)70338-0 · Cited by 41
Self-citationRampton, D. S. (2005) · Gut · doi:10.1136/gut.2005.076034 · Cited by 41
Poppers, D. M., & Scherl, E. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20261 · Cited by 40
Blonski, W. C., & Lichtenstein, G. R. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20027 · Cited by 39
Stevens, R. H., Oliver, M., Brogan, M., Heiserodt, J., & Targan, S. R. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90011-3 · Cited by 38
Krok, K. L., & Lichtenstein, G. R. (2003) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200303000-00009 · Cited by 38
The influence of zinc status and malnutrition on immunological function in Crohn's disease
Ainley, C. C., Cason, J. W., Slavin, B. M., Wolstencroft, R. A., & Thompson, R. P. H. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90660-d · Cited by 38
Hyperinfective Strongyloidiasis in the Medical Ward
Adedayo, O., GRELL, G., & Bellot, P. A. (2002) · Southern Medical Journal · doi:10.1097/00007611-200207000-00011 · Cited by 37
A case of Legionellosis during treatment with a TNFα antagonist
Wondergem, M. J., Voskuyl, A. E., & van Agtmael, M. A. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410019598 · Cited by 33
Prophylaxis of Herpesvirus Infections in Immunocompetent and Immunocompromised Older Patients
Fillet, A. (2002) · Drugs & Aging · doi:10.2165/00002512-200219050-00003 · Cited by 32
Prevention of infection in the immunocompromised host
Risi, G., & Tomascak, V. (1998) · American Journal of Infection Control · doi:10.1053/ic.1998.v26.a89371 · Cited by 29
Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohnʼs disease
Izbéki, F., Nagy, F. T., Szepes, Z., Kiss, I., Lonovics, J., & Molnár, T. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20286 · Cited by 28
Gershwin, M. E., Borchers, A. T., & Keen, C. L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315905 · Cited by 28
Disseminated Salmonella typhimurium infection secondary to infliximab treatment
Fu, A., Bertouch, J. V., & McNeil, H. P. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20639 · Cited by 25
Treatment to prevent recurrent genital herpes
Martinez, V., Caumes, É., & Chosidow, O. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282f3d9d3 · Cited by 24
Marais, D. J., Sampson, C. C., Urban, M. I., Sitas, F., & Williamson, A. (2007) · Journal of Medical Virology · doi:10.1002/jmv.20874 · Cited by 23
Pneumococcal vaccination in adults: recommendations, trends, and prospects.
Targonski, P. V., & Poland, G. A. (2007) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.74.6.401 · Cited by 23
Kilhamn, J., Lundin, S. B., Brevinge, H., Svennerholm, A., & Jertborn, M. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.3.426-430.2003 · Cited by 19
Rijkeboer, A. A., Voskuyl, A. E., & van Agtmael, M. A. (2006) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540600786549 · Cited by 18
Diagnosis of human cytomegalovirus infections in the immunocompromised host
Gerna, G., Zavattoni, M., Percivalle, E., Zella, D., Torsellini, M., & Revello, M. G. (1996) · Clinical and Diagnostic Virology · doi:10.1016/0928-0197(96)00219-x · Cited by 13
Progressive multifocal leukoencephalopathy
Berger, J. R. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)85013-5 · Cited by 13
LONG-TERM NONPROGRESSIVE HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION IN A KIDNEY ALLOGRAFT RECIPIENT
Purgus, R., Tamalet, C., Poignard, P., Spire, B., Dignat‐George, F., Robert, A., & Olmer, M. (1998) · Transplantation · doi:10.1097/00007890-199811270-00020 · Cited by 12
Gross, T. P., Khurana, R. K., Higgins, T., et al. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90919-3 · Cited by 11
Sharma, K., Rao, P., Krishnamurthy, P., Ali, S. A., & Beck, G. (2007) · Southern Medical Journal · doi:10.1097/smj.0b013e31802fb3b4 · Cited by 9
Cited by
Lamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
Ordás, I., Eckmann, L., Talamini, M., Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60150-0 · Cited by 2,078
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910
Self-citationDignass, A., Lindsay, J. O., Sturm, A., Windsor, A., Colombel, J.-F., Allez, M., D'Haens, G., D'Hoore, A., Mantzaris, G., Novacek, G., et al. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.002 · Cited by 1,548
Self-citationHarbord, M., Eliakim, R., Bettenworth, D., Karmiris, K., Katsanos, K., Kopylov, U., Kucharzik, T., Molnár, T., Raine, T., Sebastian, S., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx009 · Cited by 1,180
Self-citation
Metadata
- Authors
- Rahier, J. F., Ben-Horin, S., Chowers, Y., Conlon, C., De Munter, P., D'Haens, G., Domènech, E., Eliakim, R., Eser, A., Frater, J., Gassull, M., Giladi, M., Kaser, A., Lémann, M., Moreels, T., Moschen, A., Pollok, R., Reinisch, W., Schunter, M., Stange, E. F., Tilg, H., Van Assche, G., Viget, N., Vucelic, B., Walsh, A., Weiss, G., Yazdanpanah, Y., Zabana, Y., Travis, S. P. L., & Colombel, J. F.
- Venue
- Journal of Crohn's and Colitis
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-06
- Volume
- 3
- Issue
- 2
- Pages
- 47-91
- ISSN
- 1873-9946 (ISSN-L)
- OpenAlex
- W2106472726
- Cited by
- 738
- References
- 251
- FWCI
- 22.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.